Verve Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Verve Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia (NCT06451770) | Verve Therapeutics, Inc. | 2024-10-30 |
| Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease (NCT06112327) | Verve Therapeutics, Inc. | 2024-06-09 |
| A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease (NCT06164730) | Verve Therapeutics, Inc. | 2024-04-30 |
| A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease (NCT05398029) | Verve Therapeutics, Inc. | 2022-07-05 |
Track Verve Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.